Skip to main content
Figure 2 | Cost Effectiveness and Resource Allocation

Figure 2

From: Surrogate outcomes: experiences at the Common Drug Review

Figure 2

Percentage of drug recommendations with surrogate acceptability by therapeutic area. Y axis: Percent of surrogate outcomes with acceptability. X axis: therapeutic area. CV = cardiovascular; HIV = human immunodeficiency virus; ID = infectious disease; Misc. = miscellaneous. Non-accepted surrogates for CV: 4/5 in pulmonary arterial hypertension; ID: 4/4 in hepatitis B; diabetes: 2/2 were oral antidiabetic agents. Rocchi et al. Surrogate Outcomes at the CDR.

Back to article page